0001415889-23-015310.txt : 20231120 0001415889-23-015310.hdr.sgml : 20231120 20231120181013 ACCESSION NUMBER: 0001415889-23-015310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stefanelli Jill CENTRAL INDEX KEY: 0001980919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 231423911 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 form4-11202023_111107.xml X0508 4 2023-11-16 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001980919 Stefanelli Jill 4995 BRADENTON AVE SUITE 240 DUBLIN OH 43017 true false false false 0 Common Stock 2023-11-16 4 A 0 275000 0 A 525000 D Common Stock 2023-11-16 4 A 0 416667 0 A 941667 D Shares vest upon the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Shares vest in three equal tranches, with the first tranche vesting on June 1, 2024 (the "Initial Vesting Date"), with the remaining tranches vesting ratably annually from the Initial Vesting Date over the following two years, subject to the Reporting Person's continuous service to the Company. Gioia Gentile on behalf of Jill Stefanelli by power of attorney 2023-11-20